Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Ipsen
FDA Approves IQIRVO — Ipsen Biopharmaceuticals, Inc.

Ipsen Biopharmaceuticals announced on Thursday the U.S. FDA approval of IQIRVO (elafibranor), marking the entry of the first non-bile acid derivative ...

Geron
FDA Approves RYTELO — Geron Corporation

# FDA Approves Geron Corporation's RYTELO (imetelstat sodium) for Telomerase-Targeted Therapy Geron Corporation received FDA approval for RYTELO (ime...

Advagen
FDA Approves CARBIDOPA AND LEVODOPA — Advagen Pharma Ltd

# FDA Approves Generic Carbidopa and Levodopa from Advagen Pharma Advagen Pharma Ltd has received FDA approval for its generic formulation of carbido...

ALMAJECT
FDA Approves Unknown Drug — ALMAJECT

FDA approved ALMAJECT’s therapeutic product NDA218771, signaling a new addition to the market with potential to address significant unmet medical need...

Alembic
FDA Approves METHOTREXATE — Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Inc. has gained final FDA approval to manufacture and market the oral generic version of Methotrexate Sodium, a pivotal approv...

IPCA
FDA Approves Unknown Drug — IPCA LABS LTD

# FDA Approves IPCA Laboratories' Generic Drug Application IPCA Laboratories Limited received FDA approval for an abbreviated new drug application (A...

Novugen
FDA Approves MYCOPHENOLIC ACID — Novugen Pharma (USA) LLC.

Novugen Pharma (USA) LLC has secured FDA approval for its Abbreviated New Drug Application #ANDA216637, generic MYCOPHENOLIC ACID (MYCOPHENOLATE SODIU...

Amgen
FDA Approves BKEMV — Amgen Inc

On Wednesday, Amgen Inc announced that the U.S. FDA approved BKEMV (eculizumab-aeeb) injection, expanding its portfolio of rapid-acting, interchangeab...

BIOCON
FDA Approves Unknown Drug — BIOCON BIOLOGICS INC

BIOCON BIOLOGICS INC announced the FDA approval of its generic version of WARRIOR PHARMA INC.'s Granix (filgrastim-sndz) on Wednesday, likely sparking...

Elite
FDA Approves METHOTREXATE SODIUM — Elite Laboratories, Inc.

# FDA Approves Elite Laboratories' Generic Methotrexate Sodium Oral Formulation Elite Laboratories, Inc. has received FDA approval for its generic me...

AMGEN
FDA Approves Unknown Drug — AMGEN INC

AMGEN announced on May 16, 2024, that it has received FDA approval for its investigational new drug, signaling a significant entry into the targeted o...

EPIC
FDA Approves Unknown Drug — EPIC PHARMA LLC

Epic Pharma LLC has received FDA approval for an Abbreviated New Drug Application (ANDA 218023), projecting an impact on the market as the company man...

Dr.
FDA Approves VASOPRESSIN — Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories received FDA approval for its intravenous vasopressin generic, positioning the company to immediately capture market share in...

Ingenus
FDA Approves ALBUTEROL SULFATE — Ingenus Pharmaceuticals, LLC

Ingenus Pharmaceuticals has received FDA approval for the Abbreviated New Drug Application (ANDA 215571) targeting albuterol sulfate inhalation powder...

Neurocrine
FDA Approves INGREZZA SPRINKLE — Neurocrine Biosciences, Inc.

# FDA Approves Neurocrine Biosciences' INGREZZA SPRINKLE for Tardive Dyskinesia Treatment Neurocrine Biosciences, Inc. has received FDA approval for ...

AbbVie
FDA Approves RINVOQ — AbbVie Inc.

Attribution of this breakthrough can be reserved for the **AbbVie** approval of the oral rheumatoid arthritis therapy RINVOQ (upadacitinib). The nod r...

ALTOR
FDA Approves Unknown Drug — ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU

ALTOR BIOSCIENCE, LLC received FDA approval for its investigational therapy on April 22, marking a commercial milestone that could significantly bolst...

Scienture
FDA Approves REZENOPY — Scienture LLC

Scienture LLC announced FDA approval for REZENOPY, a generic naloxone hydrochloride nasal spray, marking the company’s entry into the rapid-growth mar...

La
FDA Approves ZEVTERA — La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company secured FDA approval for ZEVTERA (ceftobiprole medocaril sodium), positioning itself in the IV antibiotic market to ad...

Akebia
FDA Approves VAFSEO — Akebia Therapeutics, Inc.

# FDA Approves Akebia Therapeutics' VAFSEO for Anemia Treatment The FDA has approved Akebia Therapeutics' VAFSEO (vadadustat), an oral hypoxia-induci...